Wieland Douglas Scott 4
4 · CYTRX CORP · Filed Dec 13, 2011
Insider Transaction Report
Form 4
CYTRX CORPCYTR
Wieland Douglas Scott
Sr. VP - Drug Development
Transactions
- Award
Stock Option (right to buy)
2011-12-12+200,000→ 200,000 totalExercise: $0.31Exp: 2021-12-11→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Stock Option vests monthly for 36 months beginning January 12, 2012, provided Reporting Person remains in continuous employ of Issuer.